Sleep, Fatigue, and Dexamethosone in Children With Leukemia
This study has been completed.
Sponsor:
Information provided by:
National Institute of Nursing Research (NINR)
ClinicalTrials.gov Identifier:
NCT00075101
First received: January 2, 2004
Last updated: August 14, 2008
Last verified: August 2008
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | January 2, 2004 | ||||
| Last Updated Date | August 14, 2008 | ||||
| Start Date ICMJE | September 2000 | ||||
| Primary Completion Date | September 2006 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
Fatigue and sleep quality changes [ Time Frame: 10 days ] [ Designated as safety issue: No ] | ||||
| Original Primary Outcome Measures ICMJE | Not Provided | ||||
| Change History | Complete list of historical versions of study NCT00075101 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE |
|
||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Sleep, Fatigue, and Dexamethosone in Children With Leukemia | ||||
| Official Title ICMJE | Sleep, Fatigue, and Dexamethosone in Childhood Cancer | ||||
| Brief Summary | The purpose of this study is to determine the relationship between dexamethosone (steroid) and children's sleep and fatigue. |
||||
| Detailed Description | Approximately 134 children and adolescents will be enrolled. All children and adolescents will wear a wrist actigraph for two consecutive 5-day study periods. Children and adolescents will have blood drawn 2 times on Day 1 when they are on dexamethosone. Their parents will complete a sleep diary and fatigue questionnaire by telephone on Days 2 and 5 of both study periods. |
||||
| Study Type ICMJE | Interventional | ||||
| Study Phase | Phase 3 | ||||
| Study Design ICMJE | Allocation: Non-Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
||||
| Condition ICMJE | Leukemia | ||||
| Intervention ICMJE | Drug: Dexamethosone
10 day study cycle: 5 day observation pre-steroid,5 day observation post-steroid
Other Name: Mestinon |
||||
| Study Arm (s) | Experimental: Study Cycle
Intervention: Drug: Dexamethosone |
||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Completed | ||||
| Estimated Enrollment ICMJE | 134 | ||||
| Completion Date | September 2006 | ||||
| Primary Completion Date | September 2006 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Children and adolescents with Leukemia, both genders |
||||
| Gender | Both | ||||
| Ages | 5 Years to 21 Years | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Location Countries ICMJE | United States | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT00075101 | ||||
| Other Study ID Numbers ICMJE | 1-R01-NR007610-01 | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | Pamela S. Hinds, St. Jude Children's Research Hospital | ||||
| Study Sponsor ICMJE | National Institute of Nursing Research (NINR) | ||||
| Collaborators ICMJE | Not Provided | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | National Institute of Nursing Research (NINR) | ||||
| Verification Date | August 2008 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||